| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.72▼ | 4.72▼ | 4.72▼ | 4.67▼ | 4.87▼ |
| MA10 | 5.06▼ | 5.06▼ | 5.06▼ | 5.03▼ | 5.21▼ |
| MA20 | 4.98▼ | 4.97▼ | 4.98▼ | 4.95▼ | 5.02▼ |
| MA50 | 4.96▼ | 5.02▼ | 5.05▼ | 5.35▼ | N/A |
| MA100 | 5.33▼ | 5.44▼ | 5.42▼ | 5.05▼ | N/A |
| MA200 | 5.53▼ | 5.63▼ | 5.38▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.068▼ | -0.064▼ | -0.062▼ | N/A | N/A |
| RSI | 37.114▼ | 36.750▼ | 36.899▼ | N/A | N/A |
| STOCH | 16.349▼ | 16.349▼ | 16.349▼ | 12.694▼ | 18.691▼ |
| WILL %R | -96.552▼ | -96.552▼ | -96.552▼ | -88.535▼ | -89.704▼ |
| CCI | -106.819▼ | -106.819▼ | -106.819▼ | -141.048▼ | -76.144 |
|
Thursday, September 03, 2020 04:51 AM
BERWYN, Pa., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Annovis Bio Inc. (NYSE:ANVS), a clinical-stage drug platform company addressing Alzheimer's disease (AD), Parkinson's disease (PD) and other ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/20 | 4.32 | 4.51 | 4.32 | 4.50 | 15,280 |
| 24/09/20 | 4.87 | 4.87 | 4.45 | 4.45 | 27,142 |
| 23/09/20 | 4.86 | 4.86 | 4.65 | 4.67 | 19,400 |
| 22/09/20 | 5.07 | 5.1036 | 4.78 | 4.78 | 26,466 |
| 21/09/20 | 5.59 | 5.59 | 4.96 | 4.96 | 20,698 |
| 18/09/20 | 5.35 | 5.46 | 5.25 | 5.33 | 29,232 |
| 17/09/20 | 5.8339 | 5.8339 | 5.15 | 5.15 | 39,066 |
| 16/09/20 | 5.52 | 5.89 | 5.42 | 5.65 | 33,939 |
| 15/09/20 | 5.59 | 5.59 | 5.04 | 5.33 | 25,300 |
| 14/09/20 | 5.04 | 5.69 | 4.90 | 5.48 | 42,700 |
|
|
||||
|
|
||||
|
|